-
Mashup Score: 0Home - 1 hour(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Home - 6 hour(s) ago
Wednesday, September 3, 2025 11:56 am – 12:56 pm CT George R. Brown Convention Center | Houston, Texas Room: Grand Ballroom A (Theater Room 1), Level 3 CME/CNE/CPE Hybrid This 60-minute live symposium will feature 3 experts in acute leukemias discussing lessons learned from the use of asparaginase-based multiagent regimens for ALL/LBL in pediatric patients and best practices for optimizing management of asparaginase therapies in adult patients with ALL/LBL. Drs Stock, Aldoss, and Curran will review
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🧪 Stay sharp on therapeutic monitoring in acute lymphoblastic leukemia/lymphoma! Boost your confidence in managing asparaginase regimens, especially in younger adults. 🔗 https://t.co/e1y9uSJOHw #SOHO2025 #LeukemiaCare https://t.co/d9i6WGZohq
-
-
Mashup Score: 1Home - 6 hour(s) ago
Friday, September 5, 2025 11:47 am – 12:47 pm CT George R. Brown Convention Center | Houston, TX Room: Grand Ballroom A (Theater Room 1), Level 3 CME/CNE/CPE Hybrid This 60-minute symposium will feature a panel of experts in multiple myeloma who will review the intricacies of induction therapy and interventions in high-risk smoldering myeloma. They will provide expert guidance and real-world perspectives on risk assessment and individualized management in first-line therapy. Attendees will be able to
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📊 New insights for newly diagnosed multiple myeloma are here! Learn how to apply emerging clinical evidence and confidently tailor treatment strategies for your patients. 🔗 [https://t.co/9OzNrgrFJo](https://t.co/9OzNrgrFJo) #SOHO2025 #MyelomaUpdate https://t.co/m5RB9il1od
-
-
Mashup Score: 1Home - 6 hour(s) ago
Friday, September 5, 2025 11:47 am – 12:47 pm CT George R. Brown Convention Center | Houston, TX Room: Grand Ballroom A (Theater Room 1), Level 3 CME/CNE/CPE Hybrid This 60-minute symposium will feature a panel of experts in multiple myeloma who will review the intricacies of induction therapy and interventions in high-risk smoldering myeloma. They will provide expert guidance and real-world perspectives on risk assessment and individualized management in first-line therapy. Attendees will be able to
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📊 New insights for newly diagnosed multiple myeloma are here! Learn how to apply emerging clinical evidence and confidently tailor treatment strategies for your patients. 🔗 [https://t.co/9OzNrgrFJo](https://t.co/9OzNrgrFJo) #SOHO2025 #MyelomaUpdate https://t.co/m5RB9il1od
-
-
Mashup Score: 1Home - 6 hour(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🧠 Global minds unite! Join experts for insights on narcolepsy’s neurocognitive burden & diagnostic best practices. 🌍 Don’t miss this hybrid CME! 📍 https://t.co/ZXTMQoY3dc Featuring: @DAMMGoodSleep https://t.co/TnNzJMR0TL
-
-
Mashup Score: 0Home - 7 hour(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🧠 Sharpen your skills in managing CS & acromegaly! Learn to diagnose, treat safely, and follow evidence-based guidelines to improve outcomes in pituitary disorders. Don’t miss this opportunity! 🔗 https://t.co/KCbK3Rz5Om https://t.co/R8dhCLpmxr
-
-
Mashup Score: 0Home - 2 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📈 What’s new in FL & DLBCL treatment? 📦 Unpack clinical trial data on bispecific antibodies & boost your confidence in applying it to practice. Click here now: https://t.co/F8iTKK2ixe @lymphomaphilia https://t.co/c7NECmgdi7
-
-
Mashup Score: 0Home - 4 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🧬 NPC is evolving. Learn to apply the latest on immunotherapy, manage irAEs, and tailor treatment plans. Ideal for oncologists, nurses, & pharmacists. 🎯 Start the case-based activity → https://t.co/JcfNXfpCOE https://t.co/7m69cjXVYn
-
-
Mashup Score: 3Home - 4 day(s) ago
Thursday, 12 June 2025 08:00 – 09:30 CEST Allianz MiCo – Milano Convention Centre | 20149 Milan, Italy Room: Brown Hall 3 CPD Hybrid Multiple myeloma (MM) remains a challenging hematologic malignancy, with most patients experiencing relapse despite initial treatment success. The management of relapsed/refractory MM (R/R MM) has evolved significantly with the advent of novel therapies, including immunomodulatory drugs, proteasome inhibitors, monoclonal antibodies, and chimeric antigen receptor (CAR)
Source: events.medscapelive.orgCategories: General Medicine NewsTweet-
🧬 Understand how prognosis evolves through relapse cycles in MM. Gain confidence in SDM, 💊personalize treatment, and 🤝 improve communication in R/R MM care. 🔗 https://t.co/C7tcZh6Xc4 Moderated by: @jmikhaelmd https://t.co/Y6TD5omzkZ
-
-
Mashup Score: 0Home - 5 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📈 What’s new in FL & DLBCL treatment? 📦 Unpack clinical trial data on bispecific antibodies & boost your confidence in applying it to practice. Click here now: https://t.co/PTr0KjUydw @lymphomaphilia https://t.co/mOoFLxHw7l
-
🧠 Global minds unite! Join experts for insights on narcolepsy’s neurocognitive burden & diagnostic best practices. 🌍 Don’t miss this hybrid CME! 📍 https://t.co/ZXTMQoY3dc Featuring: @DAMMGoodSleep https://t.co/TnNzJMR0TL